Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair
- 31 October 2005
- journal article
- Published by Elsevier in Cardiovascular Pathology
- Vol. 14 (5), 241-246
- https://doi.org/10.1016/j.carpath.2005.05.004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Of Mice and DogsThe American Journal of Pathology, 2004
- Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factorBasic Research in Cardiology, 2004
- Myofibroblast and Endothelial Cell Proliferation during Murine Myocardial Infarct RepairThe American Journal of Pathology, 2003
- Multiple Organ Engraftment by Bone‐Marrow‐Derived Myofibroblasts and Fibroblasts in Bone‐Marrow‐Transplanted MiceThe International Journal of Cell Cloning, 2003
- Inhibition of Granulation Tissue Cell Apoptosis During the Subacute Stage of Myocardial Infarction Improves Cardiac Remodeling and Dysfunction at the Chronic StageCirculation, 2003
- The myofibroblast in wound healing and fibrocontractive diseasesThe Journal of Pathology, 2003
- The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses?Immunological Reviews, 2001
- ‘Green mice’ as a source of ubiquitous green cellsFEBS Letters, 1997
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994